329 related articles for article (PubMed ID: 23324593)
1. The pathology roadmap in Parkinson disease.
Surmeier DJ; Sulzer D
Prion; 2013; 7(1):85-91. PubMed ID: 23324593
[TBL] [Abstract][Full Text] [Related]
2. Neuronal vulnerability, pathogenesis, and Parkinson's disease.
Sulzer D; Surmeier DJ
Mov Disord; 2013 Jan; 28(1):41-50. PubMed ID: 22791686
[TBL] [Abstract][Full Text] [Related]
3. Neuronal vulnerability, pathogenesis, and Parkinson's disease.
Sulzer D; Surmeier DJ
Mov Disord; 2013 Jun; 28(6):715-24. PubMed ID: 23589357
[TBL] [Abstract][Full Text] [Related]
4. Determinants of dopaminergic neuron loss in Parkinson's disease.
Surmeier DJ
FEBS J; 2018 Oct; 285(19):3657-3668. PubMed ID: 30028088
[TBL] [Abstract][Full Text] [Related]
5. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
[TBL] [Abstract][Full Text] [Related]
7. Selective neuronal vulnerability in Parkinson's disease.
Gonzalez-Rodriguez P; Zampese E; Surmeier DJ
Prog Brain Res; 2020; 252():61-89. PubMed ID: 32247375
[TBL] [Abstract][Full Text] [Related]
8. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.
Lang A; Dassler E; Milenkovic I; Lutz MI; Kovacs GG
Parkinsonism Relat Disord; 2021 Sep; 90():57-61. PubMed ID: 34385008
[TBL] [Abstract][Full Text] [Related]
9. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
[TBL] [Abstract][Full Text] [Related]
10. [Pathological mechanisms of Parkinson's disease].
Matsui H; Takahashi R
Brain Nerve; 2009 Apr; 61(4):441-6. PubMed ID: 19378814
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
[TBL] [Abstract][Full Text] [Related]
12. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
Surmeier DJ; Halliday GM; Simuni T
Exp Neurol; 2017 Dec; 298(Pt B):202-209. PubMed ID: 28780195
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
14. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
15. Parkinson disease: from pathology to molecular disease mechanisms.
Dexter DT; Jenner P
Free Radic Biol Med; 2013 Sep; 62():132-144. PubMed ID: 23380027
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
17. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue.
Imaizumi Y; Okada Y; Akamatsu W; Koike M; Kuzumaki N; Hayakawa H; Nihira T; Kobayashi T; Ohyama M; Sato S; Takanashi M; Funayama M; Hirayama A; Soga T; Hishiki T; Suematsu M; Yagi T; Ito D; Kosakai A; Hayashi K; Shouji M; Nakanishi A; Suzuki N; Mizuno Y; Mizushima N; Amagai M; Uchiyama Y; Mochizuki H; Hattori N; Okano H
Mol Brain; 2012 Oct; 5():35. PubMed ID: 23039195
[TBL] [Abstract][Full Text] [Related]
19. What causes the death of dopaminergic neurons in Parkinson's disease?
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
Prog Brain Res; 2010; 183():59-77. PubMed ID: 20696315
[TBL] [Abstract][Full Text] [Related]
20. Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons.
Dryanovski DI; Guzman JN; Xie Z; Galteri DJ; Volpicelli-Daley LA; Lee VM; Miller RJ; Schumacker PT; Surmeier DJ
J Neurosci; 2013 Jun; 33(24):10154-64. PubMed ID: 23761910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
